Research suggests that miR-200b may play a role in inhibiting the proliferation and metastasis of breast cancer. The mechanism of this inhibition is being studied, with potential targets including fucosyltransferase IV and α1,3-fucosylated glycans. The miR-200 family is also being explored for its broader implications in cancer regulation and treatment, including its potential interactions with other cancer-related genes and pathways.